company background image
GBLX logo

GB Sciences OTCPK:GBLX Stock Report

Last Price

US$0.0046

Market Cap

US$1.6m

7D

-9.0%

1Y

-32.8%

Updated

24 Dec, 2024

Data

Company Financials

GBLX Stock Overview

A plant-based research and biopharmaceutical drug development company. More details

GBLX fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

GB Sciences, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for GB Sciences
Historical stock prices
Current Share PriceUS$0.0046
52 Week HighUS$0.013
52 Week LowUS$0.000001
Beta7.4
1 Month Change4,450.00%
3 Month Change-28.35%
1 Year Change-32.84%
3 Year Change-77.25%
5 Year Change-88.63%
Change since IPO-99.85%

Recent News & Updates

Recent updates

Shareholder Returns

GBLXUS PharmaceuticalsUS Market
7D-9.0%0.6%-0.4%
1Y-32.8%10.0%24.8%

Return vs Industry: GBLX underperformed the US Pharmaceuticals industry which returned 9.7% over the past year.

Return vs Market: GBLX underperformed the US Market which returned 23.9% over the past year.

Price Volatility

Is GBLX's price volatile compared to industry and market?
GBLX volatility
GBLX Average Weekly Movement9,917.8%
Pharmaceuticals Industry Average Movement10.5%
Market Average Movement6.3%
10% most volatile stocks in US Market17.0%
10% least volatile stocks in US Market3.1%

Stable Share Price: GBLX's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: GBLX's weekly volatility has increased from 4940% to 9918% over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a2n/awww.gbsciences.com

GB Sciences, Inc., a plant-based research and biopharmaceutical drug development company. The company offers cannabis inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson’s disease, neuropathic pain, chronic pain, cytokine release syndrome, stress/anxiety/depression, and cardiovascular therapeutic programs.

GB Sciences, Inc. Fundamentals Summary

How do GB Sciences's earnings and revenue compare to its market cap?
GBLX fundamental statistics
Market capUS$1.63m
Earnings (TTM)-US$1.14m
Revenue (TTM)n/a

0.0x

P/S Ratio

-1.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GBLX income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$1.14m
Earnings-US$1.14m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.0028
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio-32.3%

How did GBLX perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 07:50
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

GB Sciences, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution